# Dr. Reddy's Laboratories, Inc. (NYSE: RDY), Princeton, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/dr-reddys-laboratories-inc/ec3847d0-42b8-478b-bb7e-5e986389f184

> Inspection records and compliance data for Dr. Reddy's Laboratories, Inc. in Princeton, New Jersey. 5 FDA inspections on record, last inspected August 21, 2025. Publicly traded as NYSE: RDY.

---

## Details

- Name: Dr. Reddy's Laboratories, Inc.
- FEI Number: 3003989912
- Address Line 1: 107 College Rd E
- City: Princeton
- State: New Jersey
- Zip Code: 08540
- Country Name: United States
- Address: 107 College Rd E, Princeton, New Jersey 08540, United States
- Country: United States

## Stock

- Stock ticker: RDY
- Exchange: NYSE
- Share price: $14.73
- Market cap: $12.3B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1280984 - Dr. Reddy's Laboratories, Inc. - 2025-08-21 — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2025
- [483 - Dr. Reddy's Laboratories, Inc. - 2022-05-26](https://www.keypedia.com/records/483/dr-reddys-laboratories-inc/fe22d74f-f3b5-421b-bea0-b89f9cd48c63) — source: FDA, date: May 26, 2022
- [FDA Inspection 1170460 - Dr. Reddy's Laboratories, Inc. - 2022-05-26](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-inc/7a3ae12f-cbd9-42a2-9976-f980567ec048) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2022
- [EIR - Dr. Reddy's Laboratories, Inc. - 2020-02-07](https://www.keypedia.com/records/eir/dr-reddys-laboratories-inc/dc31a061-03b2-45d6-aba0-b124671e0e4f) — source: FDA, date: February 7, 2020
- FDA Inspection 1119494 - Dr. Reddy's Laboratories, Inc. - 2020-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2020
- [FDA Inspection 858994 - Dr. Reddy's Laboratories, Inc. - 2013-12-16](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-inc/740fd8a7-c0f0-487c-829d-7834822acefa) — classification: No Action Indicated (NAI), source: FDA, date: December 16, 2013
- FDA Inspection 725605 - Dr. Reddy's Laboratories, Inc. - 2011-05-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2011

## Related Companies

- [Vantage Specialty Ingredients](https://www.keypedia.com/companies/vantage-specialty-ingredients/61ceb95e-844d-4b4b-a2e9-cf927d214d27)
- [Nationwide Laboratories, LLC](https://www.keypedia.com/companies/nationwide-laboratories-llc/e5dccf31-f7a6-4a51-9f59-7e2929127933)
- [John D. Gabriel, MD](https://www.keypedia.com/companies/john-d-gabriel-md/6c8dab33-f0fe-48ec-8b27-7c62dededa1f)
- [NuSil Technology LLC](https://www.keypedia.com/companies/nusil-technology-llc/ef176ca7-d941-4939-89a4-be78633f5cb4)
- [Rpk Pharmaceuticals Inc](https://www.keypedia.com/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af)
- [Andapharm, LLC](https://www.keypedia.com/companies/andapharm-llc/62711f7a-0996-4623-93e4-87351349e6c9)
- [Mirum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mirum-pharmaceuticals-inc/9b906e94-ef88-467f-8b15-9f0b02d9e49d)
- [Shishuka Malhotra MD](https://www.keypedia.com/companies/shishuka-malhotra-md/01b66b3a-180c-4784-8210-0d1454be1832)
- [Hagop M. Kantarjian, M.D.](https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9)
- [Corden Pharma Boulder, Inc.](https://www.keypedia.com/companies/corden-pharma-boulder-inc/ac780a14-1ead-48c8-8376-cb62f7114aec)

## Related Officers

- [company_representative](https://www.keypedia.com/people/sarah-rickert/25b6eff3-27ad-4464-a24a-b979908edba8)
- [company_representative](https://www.keypedia.com/people/ganadhish-kamat/566cc66f-dc29-4eb5-afac-f242c005ff63)
- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)
- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
